Paper21833767
A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
Ilari A and 7 others. Amino Acids, 2012. Cited by 132 papers, by iCite.
Cite this record
ConductScience Library. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition. Papers, record 21833767. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21833767
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiprotozoal Agents | Major topic |
| Auranofin | Major topic |
| Biogenic Polyamines | Major topic |
| Gold | Major topic |
| Leishmania infantum | Major topic |
| NADH, NADPH Oxidoreductases | Major topic |
| Animals | |
| Models, Molecular | |
| X-Ray Diffraction |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10090783 | Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei. | J Med Chem | 1999 | https://conductscience.org/library/papers/10090783 | PubMed |
| 2 | 11123991 | (2,2':6',2"-Terpyridine)platinum(II) complexes are irreversible inhibitors of Trypanosoma cruzi trypanothione reductase but not of human glutathione reductase. | J Med Chem | 2000 | https://conductscience.org/library/papers/11123991 | PubMed |
| 3 | 16565519 | Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16565519 | PubMed |
| 4 | 3142020 | Effect of gold salt treatment on the receptor binding activity of monocytes and macrophages isolated from rats with adjuvant arthritis. | Rheumatol Int | 1988 | https://conductscience.org/library/papers/3142020 | PubMed |
| 5 | 17448941 | Cutaneous leishmaniasis treatment. | Travel Med Infect Dis | 2007 | https://conductscience.org/library/papers/17448941 | PubMed |
| 6 | 15572765 | Coot: model-building tools for molecular graphics. | Acta Crystallogr D Biol Crystallogr | 2004 | https://conductscience.org/library/papers/15572765 | PubMed |
| 7 | 19710012 | Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects. | J Biol Chem | 2009 | https://conductscience.org/library/papers/19710012 | PubMed |
| 8 | 19200044 | Trypanothione reductase from Leishmania infantum: cloning, expression, purification, crystallization and preliminary X-ray data analysis. | Protein Pept Lett | 2009 | https://conductscience.org/library/papers/19200044 | PubMed |
| 9 | 17055060 | Synthesis and characterization of [Au(dppz)2]Cl3. DNA interaction studies and biological activity against Leishmania (L) mexicana. | J Inorg Biochem | 2007 | https://conductscience.org/library/papers/17055060 | PubMed |
| 10 | 17640917 | Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17640917 | PubMed |
| 11 | 18164763 | Synthesis and characterization of platinum-sterol hydrazone complexes with biological activity against Leishmania (L.) mexicana. | J Inorg Biochem | 2008 | https://conductscience.org/library/papers/18164763 | PubMed |
| 12 | 9251892 | The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. | Gen Pharmacol | 1997 | https://conductscience.org/library/papers/9251892 | PubMed |
| 13 | 16722651 | Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets. | J Med Chem | 2006 | https://conductscience.org/library/papers/16722651 | PubMed |
| 14 | 9685351 | Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9685351 | PubMed |
| 15 | 20127392 | HIV therapeutic possibilities of gold compounds. | Biometals | 2010 | https://conductscience.org/library/papers/20127392 | PubMed |
| 16 | 11749494 | Gold-based therapeutic agents. | Chem Rev | 1999 | https://conductscience.org/library/papers/11749494 | PubMed |
| 17 | 20127591 | Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drug. | Cent Eur Neurosurg | 2010 | https://conductscience.org/library/papers/20127591 | PubMed |
| 19 | 15299926 | Refinement of macromolecular structures by the maximum-likelihood method. | Acta Crystallogr D Biol Crystallogr | 1997 | https://conductscience.org/library/papers/15299926 | PubMed |
| 20 | 7607216 | Trypanothione reductase from Leishmania donovani. Purification, characterisation and inhibition by trivalent antimonials. | Eur J Biochem | 1995 | https://conductscience.org/library/papers/7607216 | PubMed |
| 21 | 24900299 | Inhibitory Effect of Silver Nanoparticles on Trypanothione Reductase Activity and Leishmania infantum Proliferation. | ACS Med Chem Lett | 2011 | https://conductscience.org/library/papers/24900299 | PubMed |
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 132 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42943213 | In Vitro Antileishmanial Activity and Cytotoxicity Evaluation of 2-(Thiophen-2-ylmethyl)quinazolin-4(3H)-one Derivatives Against Leishmania tropica and Leishmania infantum. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943213 | PubMed |
| 42802304 | Beyond the Active Site: First-In-Class Leishmania Infantum Trypanothione Reductase Dimerization Disruptors as Antileishmanial Leads. | ChemMedChem | 2026 | https://conductscience.org/library/papers/42802304 | PubMed |
| 42334839 | Mechanism of auranofin toxicity: Inhibition of tetrahydrobiopterin metabolism. | Toxicol Appl Pharmacol | 2026 | https://conductscience.org/library/papers/42334839 | PubMed |
| 42322249 | Structural basis of ligand selectivity in FAD/NAD(P)H-dependent dehydrogenases: insights from trypanothione reductase and type II NADH dehydrogenase. | Protein Sci | 2026 | https://conductscience.org/library/papers/42322249 | PubMed |
| 41701359 | Molecular docking: a computational approach for the discovery of novel targets against visceral leishmaniasis. | J Mol Model | 2026 | https://conductscience.org/library/papers/41701359 | PubMed |
| 41304874 | Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41304874 | PubMed |
| 41176922 | Investigations of gold(I) complexes as inhibitors of caspase-1. | J Inorg Biochem | 2026 | https://conductscience.org/library/papers/41176922 | PubMed |
| 40872574 | Targeting Trypanothione Synthetase and Trypanothione Reductase: Development of Common Inhibitors to Tackle Trypanosomatid Disease. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872574 | PubMed |
| 40579895 | Beyond gold: the chemoenhancing mechanism and therapeutic potential of auranofin in melanoma. | Cancer Biol Med | 2025 | https://conductscience.org/library/papers/40579895 | PubMed |
| 39552640 | Functional utility of gold complexes with phosphorus donor ligands in biological systems. | Coord Chem Rev | 2025 | https://conductscience.org/library/papers/39552640 | PubMed |
| 39421030 | In silico approaches supporting drug repurposing for Leishmaniasis: a scoping review. | EXCLI J | 2024 | https://conductscience.org/library/papers/39421030 | PubMed |
| 39407583 | 1,2,4-Oxadiazole Derivatives: Physicochemical Properties, Antileishmanial Potential, Docking and Molecular Dynamic Simulations of Leishmania infantum Target Proteins. | Molecules | 2024 | https://conductscience.org/library/papers/39407583 | PubMed |
| 39001837 | Innovating Leishmaniasis Treatment: A Critical Chemist's Review of Inorganic Nanomaterials. | ACS Infect Dis | 2024 | https://conductscience.org/library/papers/39001837 | PubMed |
| 38792079 | Targeting Trypanothione Metabolism in Trypanosomatids. | Molecules | 2024 | https://conductscience.org/library/papers/38792079 | PubMed |
| 38675113 | Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38675113 | PubMed |
| 38244050 | Study of metalation of thioredoxin by gold(I) therapeutic compounds using combined liquid chromatography/capillary electrophoresis with inductively coupled plasma/electrospray MS/MS detection. | Anal Bioanal Chem | 2024 | https://conductscience.org/library/papers/38244050 | PubMed |
| 38206030 | Gold(I) ion and the phosphine ligand are necessary for the anti-Toxoplasma gondii activity of auranofin. | Microbiol Spectr | 2024 | https://conductscience.org/library/papers/38206030 | PubMed |
| 38009165 | Triethyl phosphine decorated cerium oxide nanoparticles exhibit selective killing of the unicellular protozoan parasite Leishmania donovani. | 3 Biotech | 2023 | https://conductscience.org/library/papers/38009165 | PubMed |
| 37631260 | Triose Phosphate Isomerase Structure-Based Virtual Screening and In Vitro Biological Activity of Natural Products as Leishmania mexicana Inhibitors. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37631260 | PubMed |
| 37333656 | Novel gold(III)-dithiocarbamate complex targeting bacterial thioredoxin reductase: antimicrobial activity, synergy, toxicity, and mechanistic insights. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37333656 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| F2R | 2149 | PubTator's text mining | https://conductscience.org/library/genes/2149 | NCBI Gene |
| TXNRD3 | 114112 | PubTator's text mining | https://conductscience.org/library/genes/114112 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21833767
GET https://conductscience.org/api/papers/v1/21833767/references?page=2